The clonal and mutational evolution spectrum of primary triple-negative breast cancersSohrab P. Shah, J Costello, Andrew Roth et al.|Nature|2012Cited by 2k
Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben‐David, Todd R. Golub, Guillaume Kugener et al.|Nature|2018Cited by 943
Patient-derived xenografts undergo mouse-specific tumor evolutionUri Ben‐David, Todd R. Golub, Gavin Ha et al.|Nature Genetics|2017Cited by 716
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J. Aguirre, William C. Hahn, Robin M. Meyers et al.|Cancer Discovery|2016Cited by 632
Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Sohrab P. Shah, Gavin Ha et al.|The Journal of Pathology|2013Cited by 434